Loading portfolio…
Loading portfolio…
| # | Issuer | Value | Shares | % Portfolio |
|---|---|---|---|---|
| 1 | BridgeBio Pharma Inc. (BBIO) | $378.0M | 5089611 | 79.35% |
| 2 | Syndax Pharmaceuticals, Inc. (SNDX) | $30.8M | 1316806 | 6.46% |
| 3 | Monte Rosa Therapeutics Inc (GLUE) | $25.6M | 1555664 | 5.37% |
| 4 | Bicara Therapeutics Inc. (BCAX) | $11.3M | 568919 | 2.38% |
| 5 | BridgeBio Oncology Therapeutics (BBOT) | $9.1M | 1018018 | 1.91% |
| 6 | Compass Pathways Plc (CMPS) | $7.9M | 1432336 | 1.66% |
| 7 | Scholar Rock Holding Corporation (SRRK) | $3.8M | 77031 | 0.80% |
| 8 | Biomea Fusion Inc (BMEA) | $3.1M | 2048757 | 0.66% |
| 9 | Eupraxia Pharmaceuticals Inc. (EPRX) | $2.4M | 325000 | 0.49% |
| 10 | Urogen Pharma Ltd. (URGN) | $1.9M | 108000 | 0.41% |
| 11 | Aclaris Therapeutics Inc (ACRS) | $1.6M | 434455 | 0.34% |
| 12 | Marker Therapeutics, Inc. (MRKR) | $423K | 325370 | 0.09% |
| 13 | OnKure Therapeutics, Inc. (OKUR) | $367K | 88607 | 0.08% |
Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.